Nanocarriers for Stroke Therapy: Advances and Obstacles in Translating Animal Studies
Syed Abdullah Alkaff, 1 Krishna Radhakrishnan, 1 Anu Maashaa Nedumaran, 1 Ping Liao, 2 Bertrand Czarny 1, 3 1School of Materials Science and Engineering, Nanyang Technological University 639798, Singapore; 2Calcium Signalling Laboratory, National Neuroscience Institute 308433, Singapore; 3Lee Kon...
Guardado en:
Autores principales: | Alkaff SA, Radhakrishnan K, Nedumaran AM, Liao P, Czarny B |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/09845ea5166c44c680f130b5e37f95f1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Thrombolytic Agents: Nanocarriers in Targeted Release
por: Minghua Shen, et al.
Publicado: (2021) -
Extracellular Vesicles – Advanced Nanocarriers in Cancer Therapy: Progress and Achievements
por: Huyan T, et al.
Publicado: (2020) -
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
por: Din FU, et al.
Publicado: (2017) -
Physicochemical characterization of drug nanocarriers
por: Manaia EB, et al.
Publicado: (2017) -
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study
por: Cova E, et al.
Publicado: (2019)